secwatch.observer — SEC 8-K summary
======================================

Issuer:     CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
CIK:        0001801170
Form:       8-K
Filed at:   2026-02-26T23:59:59+00:00
Accession:  0001801170-26-000050
Event type: earnings
Sentiment:  positive
Materiality: 0.90
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud

Clover Health Reports FY2025 Revenue Up 40% to $1.9B, Guides to First GAAP Net Income Profitability in FY2026
--------------------------------------------------------------------------------

- Full year 2025 total revenues of $1.9 billion, up 40% year-over-year; GAAP net loss of $86 million.
- Adjusted EBITDA of $22 million for 2025; Medicare Advantage membership grew 38% to 113,803.
- Full year 2026 guidance: revenues $2.81B-$2.92B, GAAP net income $0M-$20M, Adjusted EBITDA $50M-$70M.
- Expects first full year of GAAP Net Income profitability in 2026 driven by improving cohort economics and Clover Assistant.
- 2026 average Medicare Advantage membership guided to 154,000-158,000, representing 46% growth at midpoint.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1801170/000180117026000050/0001801170-26-000050-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1801170/000180117026000050/clov-20260226.htm
  HTML page:      https://secwatch.observer/filing/0001801170-26-000050

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer